Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A note on sample size calculation for mean comparisons based on noncentral t-statistics.

Shein-Chung Chow1, Jun Shao, Hansheng Wang

  • 1StatPlus, Inc., Heston Hall, Suite 206, 1790 Yardley-Langhorne Road, Yardley, PA 19067, USA.

Journal of Biopharmaceutical Statistics
|December 13, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Delphinidin targets voltage-dependent anion channel 1 to inhibit ferroptosis and protect against retinal photochemical damage.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same author

Genome-wide analysis of the <i>GID</i> gene family in soybean and analysis of expression under gibberellin treatment.

Frontiers in plant science·2026
Same author

Decentralized EM algorithm for Gaussian mixtures under data heterogeneity and partial labeling.

Biometrics·2026
Same author

Efficacy and safety of ultrasound-guided microwave ablation for primary hyperparathyroidism: a dual-centre study.

Scientific reports·2026
Same author

Multiscale multimodal graph convolutional networks for identifying essential tremor and dystonic tremor.

Neurobiology of disease·2026
Same author

Correction: RBX1 regulates PKM alternative splicing to facilitate anaplastic thyroid carcinoma metastasis and aerobic glycolysis by destroying the SMAR1/HDAC6 complex.

Cell & bioscience·2026

Sample size calculations for clinical trials are essential for detecting meaningful differences between drug products. This study provides formulas for t-tests across various trial designs, aiding researchers in planning effective studies.

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Pharmacometrics

Background:

  • One-sample and two-sample t-tests are fundamental statistical tools for comparing mean drug responses in clinical trials.
  • Accurate sample size calculation is critical during clinical study planning to ensure sufficient statistical power for detecting clinically relevant differences.
  • Existing methods may not cover all common clinical trial designs and hypothesis testing scenarios.

Purpose of the Study:

  • To derive and present sample size calculation formulas for various t-test applications in clinical trials.
  • To provide methods for testing drug product equality, noninferiority/superiority, and equivalence.
  • To support sample size determination across one-sample, two-sample parallel, and two-sample crossover designs.

Main Methods:

Related Experiment Videos

  • Derivation of sample size formulas based on noncentral t-distributions.
  • Application of formulas to one-sample, two-sample parallel, and two-sample crossover study designs.
  • Development of useful tables and illustrative examples for practical application.

Main Results:

  • Novel sample size calculation formulas are presented for testing equality, noninferiority/superiority, and equivalence.
  • Formulas are applicable to commonly used clinical trial designs.
  • Constructed tables and examples facilitate the practical use of these formulas in study planning.

Conclusions:

  • The derived formulas and presented tables offer a comprehensive resource for sample size calculations in drug development.
  • These tools enhance the rigor of clinical trial planning by ensuring adequate power for hypothesis testing.
  • The methodology supports informed decision-making in comparing drug product efficacy and therapeutic claims.